Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term outcome of hepatitis delta in different regions world-wide: Results of the Hepatitis Delta International Network.
Wranke A, Lobato C, Ceausu E, Dalekos GN, Rizzetto M, Turcanu A, Niro GA, Keskin O, Gherlan G, Abbas M, Ingiliz P, Muche M, Buti M, Jachs M, Vanwolleghem T, Cornberg M, Abbas Z, Yurdaydin C, Dörge P, Wedemeyer H; Hepatitis Delta International Network. Wranke A, et al. Among authors: lobato c. Liver Int. 2024 Sep;44(9):2442-2457. doi: 10.1111/liv.16006. Epub 2024 Jun 18. Liver Int. 2024. PMID: 38888267
Direct antiviral therapy for treatment of hepatitis C: A real-world study from Brazil.
Lobato CMO, Codes L, Silva GF, Souza AFM, Coelho HSM, Pedroso MLA, Parise ER, Lima LMSTB, Borba LA, Evangelista AS, Rezende REF, Cheinquer H, Kuniyoshi ASO, Aires RS, Quintela EHD, Mendes LSC, Nascimento FCV, Medeiros Filho JEM, Ferraz MLCG, Abdala E, Bittencourt PL; Members of the Brazilian Real-Life Study about HCV treatment; Members of the Brazilian Real-Life Study about HCV treatment. Lobato CMO, et al. Ann Hepatol. 2019 Nov-Dec;18(6):849-854. doi: 10.1016/j.aohep.2019.08.001. Epub 2019 Aug 30. Ann Hepatol. 2019. PMID: 31537509 Free article.
Effectiveness of first-wave protease inhibitors in hepatitis C virus genotype 1 infection: a multicenter study in Brazil.
Lobato CMO, Balassiano N, Hyppolito EB, Sanchez-Lermen RLP, Signorelli IV, Nicacio MYT, Firmino Filho AP, Andrade TG, Lima JMC, Arruda TA, Coutinho FS, Araujo EFDV, Esmeraldo TM, Cortez E, Capeli RLA, Matos MBM, Pessoa FSR, Oliveira HC, Arruda ÉAG, Gonçalves PL, Araújo Filho AH, Esberard EBC, Souto FJD. Lobato CMO, et al. Rev Soc Bras Med Trop. 2018 Jan-Feb;51(1):14-20. doi: 10.1590/0037-8682-0279-2017. Rev Soc Bras Med Trop. 2018. PMID: 29513836 Free article. Clinical Trial.
Weight-based combination therapy with peginterferon alpha-2b and ribavirin for naïve, relapser and non-responder patients with chronic hepatitis C.
Gonçales FL Jr, Vigani A, Gonçales N, Barone AA, Araújo E, Focaccia R, Oliveira U, Coelho HS, Paixao J, Perez R, Lobato C, Weirich J, Rosa H, Borges A, Vila R, Corrêa-Giannella ML, Ferraz ML. Gonçales FL Jr, et al. Among authors: lobato c. Braz J Infect Dis. 2006 Oct;10(5):311-6. doi: 10.1590/s1413-86702006000500002. Braz J Infect Dis. 2006. PMID: 17293917
Rational Approach to New Chemical Entities with Antiproliferative Activity on Ab1 Tyrosine Kinase Encoded by the BCR-ABL Gene: An Hierarchical Biochemoinformatics Analysis.
Sanches VHDS, Lobato CC, Silva LB, Dos Santos IVF, Barros ES, Maciel AA, Ferreira EFB, da Costa KS, Espejo-Román JM, Rosa JMC, Kimani NM, Santos CBR. Sanches VHDS, et al. Among authors: lobato cc. Pharmaceuticals (Basel). 2024 Nov 6;17(11):1491. doi: 10.3390/ph17111491. Pharmaceuticals (Basel). 2024. PMID: 39598402 Free PMC article.
73 results